Detalles de la búsqueda
1.
Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspective.
Support Care Cancer
; 30(11): 9307-9315, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36074186
Resultados
1 -
1
de 1
1
Próxima >
>>